C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 38/17 (2006.01) C07K 14/47 (2006.01) C12N 5/10 (2006.01) C12N 15/86 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2401545
Methods of treating tumors, preventing restenosis, and treating hyperplasias, corneal haze, and cataracts by administering to an animal a mutated cyclin G1 protein. The mutated cyclin G1 protein may be administered to an animal by administering to an animal an expression vehicle, such as a retroviral vector comprising a gene construct encoding a mutated cyclin G1 protein.
L'invention concerne des méthodes permettant de traiter des tumeurs, de prévenir une resténose et de traiter une hyperplasie, une opacité cornéenne et des cataractes par l'administration d'une protéine cycline G1 mutée à un animal. Cette protéine peut être administrée à un animal par l'administration d'un véhicule d'expression, tel qu'un vecteur rétroviral renfermant un gène chimère codant pour une protéine cycline G1 mutée.
Gordon Erlinda Maria
Hall Frederick L.
Fetherstonhaugh & Co.
University Of Southern California
LandOfFree
Mutated cyclin g1 protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mutated cyclin g1 protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutated cyclin g1 protein will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1435458